CareFusion-Becton Dickinson merger gets shareholder approval | BioFire buy drives 2014 revenue growth for BioMerieux | Surgical solutions, new offerings drive Q1 profit growth for Covidien
January 23, 2015
ADVAMED SmartBrief
News for medical technology professionals

Top Story
CareFusion-Becton Dickinson merger gets shareholder approval
Shareholders on Thursday approved CareFusion's proposed $12 billion merger with Becton Dickinson, which will close once it is approved by the European Commission. About 76% of the outstanding shares of CareFusion chose to clear the deal, the companies said. (Boston) (1/22)
Share: LinkedInTwitterFacebookGoogle+Email
5 tips for managing negative online comments
The Internet gives your customers a voice online, but what can you do when that voice is yelling negative comments? With 5 tips, you can learn how to positively respond and help direct the conversation. Read the article and learn the 5 ways to respond positively.

Business & Market TrendsSponsored By
BioFire buy drives 2014 revenue growth for BioMerieux
BioMerieux said its total revenue increased to $1.9 billion for the 12 months ending Dec. 31, which was up 7% from 2013. The French in vitro diagnostic company said the growth was aided by its acquisition of BioFire, which posted year-over-year sales growth of more than 60% on the back of solid sales for its FilmArray respiratory panel. BioMerieux aims to improve its organic revenue by 4.5% to 6.5% this year. GenomeWeb Daily News (free registration) (1/22)
Share: LinkedInTwitterFacebookGoogle+Email
Surgical solutions, new offerings drive Q1 profit growth for Covidien
Covidien posted a 28.4% rise in profits to $511 million for the quarter ending Dec. 26 on sales of $2.69 billion. The growth was driven by new key offerings, a sustained focus on improving productivity and significant growth in surgical solutions. Covidien's $43 billion merger with Medtronic could close next week. (Boston) (1/22)
Share: LinkedInTwitterFacebookGoogle+Email
San Diego-based cancer Dx firm to sell 6.3 million shares in IPO
Biocept filed plans Wednesday with the Securities and Exchange Commission to sell about 6.3 million company shares in an initial public offering. The San Diego-based oncology diagnostics firm plans to use the proceeds from the IPO for validating and developing tests in its pipeline, scale-up and automation, as well as marketing and sales of its tests. GenomeWeb Daily News (free registration) (1/22)
Share: LinkedInTwitterFacebookGoogle+Email
The IDC Market Spotlight on Network Automation and Agility
The arrival of virtualization, cloud computing, and mobility has strained data center networks—and IT staff—like never before. This Market Spotlight explains how data center network fabrics provide a foundation for automated provisioning, configuration, and management of network-based services in a new era of IT agility. Download now.

International Developments
Molecular Dx firm, Norwegian hospital team up in cancer Dx deal
University Hospital Oslo has entered into a cancer diagnostics deal with New Oncology, a German molecular diagnostic company, for undisclosed terms. Under the deal, New Oncology said it will use the advanced sequencing diagnostic platform Neo to spot changes in cancer-linked genes to predict the resistance or response to targeted treatments. GenomeWeb Daily News (free registration) (1/22)
Share: LinkedInTwitterFacebookGoogle+Email
Report: Worldwide MRI market could be worth over $9.2B by 2020
A GlobalData report predicts the worldwide market for MRI systems could grow from about $4.1 billion in 2013 to over $9.2 billion by 2020. The more-than-twofold increase will be driven in part by reimbursement gains, cost reductions and improvements in design, the report found. (free registration) (1/22)
Share: LinkedInTwitterFacebookGoogle+Email
Science & Health
U.S. grants 66 patents to Carestream Health in 2014
The U.S. Patent and Trademark Office granted 66 patents to Carestream Health last year for innovations in various areas of health care, including radiology imaging. Among the patents awarded to the company were enhancements to its portfolio of solutions designed to oversee, share and save patient information and advancements in its radiology tools that could boost the quality of clinical images for providers. (free registration) (1/22)
Share: LinkedInTwitterFacebookGoogle+Email
Government & Regulatory
FDA OKs collagen bone graft from BioStructures
The FDA has given BioStructures, a Newport Beach, Calif., medtech firm, clearance to market its advanced Silhouette Mineralized Collagen Scaffold Bone Graft. The product, which has a 90% porous matrix, facilitates the delivery of crucial biologic factors such as bone marrow aspirate to stimulate healing. FDAnews (1/22)
Share: LinkedInTwitterFacebookGoogle+Email
FDA is committed to U.S. trials of medical devices
The FDA has made the first step in its commitment to give U.S. patients first access to effective and safe medical devices by making sure that rigorous clinical studies of the products are conducted in the U.S., write Dr. Jeffrey Shuren and Owen Faris of the FDA's Center for Devices and Radiological Health. FDA Voice blog (1/21)
Share: LinkedInTwitterFacebookGoogle+Email
AdvaMed News
Helping medical technology professionals keep pace with regulatory and compliance issues
AdvaMed-MTLI and UL EduNeering have recently launched the AdvaMed Regulatory and Compliance Certificate (ARCC) Program for Medical Technology Professionals. The ARCC Program is a relevant and timely collaboration between AdvaMed and UL EduNeering that helps medical technology professionals to expand their knowledge of quality, regulatory and compliance topics. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
See AdvaMed-MTLI's schedule of courses
Continue your professional development! See AdvaMed-MTLI's schedule of courses.
Share: LinkedInTwitterFacebookGoogle+Email
Who's Hiring?
Position TitleCompany NameLocation
Global Medical Safety Director - Transcatheter Heart ValveEdwards LifesciencesIrvine, CA
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3AbbottChicago, IL
Senior Regulatory Affairs Specialist Abbott Medical Devices (PDP Program) - 1400000AQGAbbottSanta Clara, CA
Director of System QALifeWatch Services, Inc.Rosemont, IL
R&D EngineerAccess Scientific San Diego, CA, CA
Project Manager RA (US/UA/00/0105/SL) - 1400000A7FAbbottSan Jose, CA
Associate Director Regulatory Affairs - 14000005JSAbbottSan Jose, CA
Sr Specialist RA AD Promo - 14000007LWAbbottSanta Ana, CA
Sr Specialist Regulatory Affairs - 14000005XIAbbottSan Jose, CA
Click here to view more job listings.
Rough diamonds may sometimes be mistaken for worthless pebbles."
-- Thomas Browne,
English author
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Lisa Gough
Advertising:  Meryl Harold
  P: 202.407.7828
Jobs Contact:  Elizabeth Stack

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information